Skip to content

Clinical trials

Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Country / region: Greece Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20091
20122
20132
20161
20191
20201
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie3
European Organisation for Research and Treatment of Cancer - EORTC2
Janssen Research & Development, LLC2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Genzyme, a Sanofi Company1
Gilead Sciences1
Hoffmann-La Roche1
Leukemia Research Fund1
Octapharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell16
Neoplasms5
Recurrence5
Leukemia3
Leukemia, Myeloid, Acute3
Lymphoma, Follicular3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Mantle-Cell3
Lymphoma, Non-Hodgkin3
Multiple Myeloma3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.